Rowland Christopher R, Little Dianne, Guilak Farshid
Department of Orthopaedic Surgery and Biomedical Engineering, Duke University Medical Center, Durham, NC 27710, USA.
J Long Term Eff Med Implants. 2012;22(3):181-93. doi: 10.1615/jlongtermeffmedimplants.2013006120.
Musculoskeletal connective tissues such as tendon, ligament, and cartilage possess a limited ability for self-repair. Tissue engineering seeks to use combinations of cells, bioactive molecules, and biomaterials to develop new treatment options for the repair or replacement of damaged tissues. The use of native extracellular matrix as scaffold material for tissue engineering has become increasingly attractive because such tissues can not only provide structural support, but also regulate cell behavior. Although demineralized bone matrix has long been recognized for its osteoinductive abilities, recent studies have identified the ability of cartilage and tendon extracellular matrices to stimulate the differentiation of mesenchymal or adipose-derived adult stem cells toward chondrogenic or tenogenic lineages, respectively. This review discusses the motivation for fabricating scaffolds from musculoskeletal tissues, the in vitro and in vivo efficacy of these tissue-derived scaffolds, and various processing techniques such as decellularization or cross-linking that can mitigate immunogenic responses, moderate the degradation profile, and enhance the mechanical properties of these constructs following long-term implantation in vivo.
肌腱、韧带和软骨等肌肉骨骼结缔组织的自我修复能力有限。组织工程旨在利用细胞、生物活性分子和生物材料的组合来开发新的治疗方案,用于修复或替换受损组织。使用天然细胞外基质作为组织工程的支架材料变得越来越有吸引力,因为这类组织不仅能提供结构支撑,还能调节细胞行为。尽管脱矿骨基质长期以来因其骨诱导能力而得到认可,但最近的研究发现,软骨和肌腱细胞外基质分别具有刺激间充质或脂肪来源的成体干细胞向软骨生成或肌腱生成谱系分化的能力。本文综述了用肌肉骨骼组织制造支架的动机、这些组织衍生支架的体外和体内功效,以及各种处理技术,如脱细胞或交联,这些技术可以减轻免疫原性反应、调节降解过程,并在体内长期植入后增强这些构建体的机械性能。